Shopping Cart
- Remove All
- Your shopping cart is currently empty
KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1]. |
In vitro | KW-8232 is an anti-osteoporotic agent that reduces PGE2 biosynthesis in mouse osteoblastic cells[1] and exhibits anti-viral activity against SARS-CoV-2 (EC50 ~1.2 μM)[2]. |
In vivo | KW-8232 (3, 10, 30 mg/kg, p.o.) significantly increases femoral bone mineral density (BMD) in immobilized rat legs and modulates immobilization-induced abnormal bone turnover. At 30 mg/kg, it markedly reduces urinary calcium excretion, pyridinoline, and deoxypyridinoline—markers of bone resorption—in neurectomized rats. KW-8232's inhibition of bone loss may be linked to decreased prostaglandin (PG)-stimulated bone resorption through regulation of PGE2 production[1]. |
Molecular Weight | 705.27 |
Formula | C37H41ClN4O6S |
Cas No. | 217813-15-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 125 mg/mL (177.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.